Back to Results

Hinge Health Inc (HNGE)

Hinge Health Inc. is a healthcare company listed on the NYSE under the ticker HNGE. The company develops a technology-enabled platform intended to scale and automate care delivery, with a focus on musculoskeletal, or MSK, conditions. Its services are designed to support patients dealing with acute injuries, chronic pain, and rehabilitation after surgery. Hinge Health’s approach combines AI-based motion tracking with a proprietary electrical nerve stimulation wearable to provide personalized and automated MSK care. The company primarily serves self-insured employers. Founded in 2012, Hinge Health is headquartered in San Francisco, California.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-HNGE
$70.75
-16.7% Downside
Fair
$90.87
6.9% Upside
Fair
Good
—
—
—
0.0%
August 4, 2026
-12.8x
58.6x
10.1x
6.786 B
6.346 B
0.1%
59.0%
6.2
—
-40.8%
Send a message
Valuation • Fair Value

Hinge Health Inc (NYSE-HNGE) Fair Value by Valuation Model

Compare the primary fair value estimate for Hinge Health Inc (NYSE-HNGE) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$70.75

Estimated downside of 16.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$78.12

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$63.37

Comparable-company valuation reference.

Analyst Price Target

$90.87

Analysts imply upside of 6.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Hinge Health Inc (NYSE-HNGE) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Hinge Health Inc (NYSE-HNGE)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

646.3 M

Current operating scale indicator.

Revenue Forecast

821.6 M

Forward revenue estimate.

EBITDA

-525.3 M

Current operating profitability reference.

EBITDA Forecast

228.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Hinge Health Inc (NYSE-HNGE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Hinge Health Inc (NYSE-HNGE)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-6.54

No elevated caution signal from this screen.

Altman Z-Score

6.2

Relatively strong balance-sheet zone.

FCF / Net Income

-40.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Hinge Health Inc (NYSE-HNGE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Hinge Health Inc (NYSE-HNGE)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Hinge Health Inc (NYSE-HNGE), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Hinge Health Inc (NYSE-HNGE) Stock Forecast & Technical Outlook

Review Hinge Health Inc (NYSE-HNGE) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Hinge Health Inc (NYSE-HNGE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Hinge Health Inc (NYSE-HNGE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Hinge Health Inc (NYSE-HNGE) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Hinge Health Inc (NYSE-HNGE) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Hinge Health Inc (NYSE-HNGE) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Hinge Health Inc (NYSE-HNGE)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Hinge Health Inc (NYSE-HNGE) has a Strong Buy consensus, with 8 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 8
Hold 1
Sell 0
FAQ • Fast Investor Answers

Hinge Health Inc (NYSE-HNGE) Stock FAQ

Quick answers about Hinge Health Inc (NYSE-HNGE) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$70.75
Estimated downside 16.7%
Valuation Rating
Overvalued
Estimated downside of 16.7%
Analyst Target
$90.87
Implied upside 6.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Hinge Health Inc (NYSE-HNGE) is $70.75. This implies an estimated downside of 16.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 16.7% versus the current market price.

The available analyst price target for Hinge Health Inc (NYSE-HNGE) is $90.87. The analyst target implies estimated upside of 6.9%.

The current financial health read for Hinge Health Inc (NYSE-HNGE) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Hinge Health Inc (NYSE-HNGE) is August 4, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Hinge Health Inc (NYSE-HNGE) is -12.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Hinge Health Inc is 6.786 B.

The current enterprise value listed for Hinge Health Inc is 6.346 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Hinge Health Inc is NYSE-HNGE, and the stock is listed on NYSE.

Hinge Health Inc (NYSE-HNGE) is listed on NYSE.

The current debt-to-total-capital ratio listed for Hinge Health Inc is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Hinge Health Inc is 59.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on NYSE View more

Unitedhealth Group (UNH) Unitedhealth Group (UNH)
CVS Health Corp (CVS) CVS Health Corp (CVS)
McKesson Corporation (MCK) McKesson Corporation (MCK)
Elevance Health Inc (ELV) Elevance Health Inc (ELV)
HCA Holdings Inc (HCA) HCA Holdings Inc (HCA)
Cigna Corp (CI) Cigna Corp (CI)
Cencora Inc (COR) Cencora Inc (COR)
Cardinal Health Inc (CAH) Cardinal Health Inc (CAH)
Humana Inc (HUM) Humana Inc (HUM)
Centene Corp (CNC) Centene Corp (CNC)
Labcorp Holdings Inc (LH) Labcorp Holdings Inc (LH)
Quest Diagnostics Incorporated (DGX) Quest Diagnostics Incorporated (DGX)
Tenet Healthcare Corporation (THC) Tenet Healthcare Corporation (THC)
DaVita HealthCare Partners Inc (DVA) DaVita HealthCare Partners Inc (DVA)
Fresenius Medical Care Corporation (FMS) Fresenius Medical Care Corporation (FMS)
Molina Healthcare Inc (MOH) Molina Healthcare Inc (MOH)
Encompass Health Corp (EHC) Encompass Health Corp (EHC)
Universal Health Services Inc (UHS) Universal Health Services Inc (UHS)
Hims Hers Health Inc (HIMS) Hims Hers Health Inc (HIMS)
PACS Group Inc (PACS) PACS Group Inc (PACS)
Chemed Corp (CHE) Chemed Corp (CHE)
Concentra Group Holdings Parent Inc (CON) Concentra Group Holdings Parent Inc (CON)
Brookdale Senior Living Inc (BKD) Brookdale Senior Living Inc (BKD)
National HealthCare Corporation (NHC) National HealthCare Corporation (NHC)